Phase II trial of carboplatin, gemcitabi
โ
Bryan J. Schneider; Basil El-Rayes; Jeffery H. Muler; Philip A. Philip; Gregory
๐
Article
๐
2007
๐
John Wiley and Sons
๐
English
โ 92 KB
๐ 1 views
## Abstract ## BACKGROUND. The purposes of this study were to evaluate efficacy and toxicity of the combination of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site (CUP). ## METHODS. Patients with CUP received carboplatin AUC 5 mg/mL a minute intraven